update on study 19 trial of olaparib in serous ovarian cancer
Published 8 years ago • 407 plays • Length 2:40Download video MP4
Download video MP3
Similar videos
-
1:40
neo trial: neoadjuvant olaparib in platinum-sensitive relapsed high-grade serous ovarian cancer
-
6:21
update on olaparib in ovarian cancer
-
3:58
solo-1: practice changing data on olaparib for ovarian cancer
-
1:13
comparison of trials of niraparib, olaparib and rucaparib in ovarian cancer
-
26:02
updates in ovarian cancer: frontline maintenance
-
1:23
dr. robertson on olaparib for serous ovarian cancer
-
2:27
the paola-1 study: olaparib and bevacizumab for ovarian cancer
-
2:18
#esmo21 highlights on maintenance olaparib in ovarian cancer previously treated with parpi
-
0:40
dr. willmott on fda approval of maintenance olaparib in ovarian cancer
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
2:23
dr. poveda on the results of the solo2 trial in ovarian cancer
-
11:22
olaparib in ovarian cancer
-
1:11
dr. ledermann on the additive effects of olaparib and bevacizumab in ovarian cancer
-
7:39
ovarian news from esmo 2018: solo-1 results for olaparib
-
3:10
overview of engot-ov16/nova of niraparib in ovarian cancer and why the results were not surprising
-
1:26
esmo 2014: phase ii study 19 quality of life study of olaparib in ovarian cancer
-
8:26
the impact of paola-1 on frontline treatment of ovarian cancer
-
1:04
olaparib maintenance therapy in ovarian cancer
-
5:48
solo1: 7-year follow-up highlights the value of maintenance olaparib